Selexipag
5 mg
| Purity Not Available
TargetMol
Selexipag(NS-304) is prostacyclin receptor agonist that causes vasodilation in pulmonary vasculature and is used in the therapy of pulmonary arterial hypertension (PAH).
More Information
Supplier Page
Selexipag
50 mg
| Purity Not Available
TargetMol
Selexipag(NS-304) is prostacyclin receptor agonist that causes vasodilation in pulmonary vasculature and is used in the therapy of pulmonary arterial hypertension (PAH).
More Information
Supplier Page
TargetMol
TargetMol
Lumefantrine is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with artemether for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
More Information
Supplier Page
TargetMol
Lumefantrine is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with artemether for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
More Information
Supplier Page
TargetMol
TargetMol
TargetMol
Piribedil
100 mg
| Purity Not Available
TargetMol
Piribedil
50 mg
| Purity Not Available
TargetMol